sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> atherosclerosis market

report

Atherosclerosis Market, by Therapy (Cholesterol-Lowering Medications, Antiplatelet Drugs & Anticoagulants, Beta Blockers, Diuretics (Water Pills), Angiotensin Converting Enzyme Inhibitors, Others), Surgery (Bypass Surgery, Angioplasty, Atherectomy), Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies, Clinics) - Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

HC246 January 2017 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the atherosclerosis market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the atherosclerosis market. The scope of this report covers the atherosclerosis market by its major segments, which include the therapies, surgeries, distribution channels, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players and innovators influencing this market

KEY PREMIUM INDUSTRY INSIGHTS

  • An increasing prevalence of heart attacks owing to the coronary heart diseases or atherosclerosis is projected to increase the demand for the atherosclerosis market during the forecast period.
  • The strong rise in the geriatric population coupled with the increasing population of baby boomers is anticipated to boost the demand for the atherosclerosis market.
  • However, the less efficacy of drugs and the side effect associated with this treatment are likely to restrain the market growth in the study period.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s atherosclerosis market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the atherosclerosis market by the following segments:

  • Atherosclerosis Market, by Therapy
    • Cholesterol-Lowering Medications
    • Antiplatelet Drugs and Anticoagulants
    • Beta Blockers
    • Diuretics (Water Pills)
    • Angiotensin Converting Enzyme Inhibitors
    • Others
  • Atherosclerosis Market, by Surgery
    • Bypass Surgery
    • Angioplasty
    • Atherectomy
  • Atherosclerosis Market, by Distribution Channels
    • Hospital Pharmacies
    • Drug Stores
    • Retail Pharmacies
    • Clinics

KEY MARKET PLAYERS

Key players in the atherosclerosis market include:

  • Merck
  • GlaxoSmithKline plc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Johnson and Johnson
  • Sanofi
  • Bayer AG
  • Anthera Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Cardium Therapeutics

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Atherosclerosis Market

TRENDING RELATED REPORT


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Regulatory Analysis
    3. Ecosystem Analysis
  5. ATHEROSCLEROSIS MARKET, BY THERAPY
    1. Segment Share
    2. Therapy
      1. Cholesterol-Lowering Medications
      2. Antiplatelet Drugs and Anticoagulants
      3. Beta Blockers
      4. Diuretics (Water Pills)
      5. Angiotensin Converting Enzyme Inhibitors
      6. Others
  6. ATHEROSCLEROSIS MARKET, BY SURGERY
    1. Segment Share
    2. Surgery
      1. Bypass Surgery
      2. Angioplasty
      3. Atherectomy
  7. ATHEROSCLEROSISMARKET, BY DISTRIBUTION CHANNELS
    1. Segment Share
    2. Distribution Channels
      1. Hospital Pharmacies
      2. Drug Stores
      3. Retail Pharmacies
      4. Clinics
  8. THEROSCLEROSIS MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Therapy
      3. By Surgery
      4. By Distribution Channels
    2. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Therapy
      3. By Surgery
      4. By Distribution Channels
    3. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Therapy
      3. By Surgery
      4. By Distribution Channels
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East and Africa
      2. By Therapy
      3. By Surgery
      4. By Distribution Channels
  9. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2015
    2. Key Innovators
  10. KEY MARKET PLAYERS
    1. Merck
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. GlaxoSmithKline plc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. F. Hoffmann-La Roche Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Novartis AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Johnson and Johnson
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Sanofi
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Bayer AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Anthera Pharmaceuticals, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Ionis Pharmaceuticals, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Cardium Therapeutics
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us